Outlook Therapeutics

OTLK stock is not Shariah-compliant

Last updated:

About Outlook Therapeutics (OTLK)

Outlook Therapeutics is a late clinical-stage biopharmaceutical company focused on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate, ONS-5010, is an ophthalmic formulation of bevacizumab in Phase-III clinical trial for treating wet age-related macular degeneration and other retina diseases. The company has collaboration and license agreements with various pharmaceutical companies.

Frequently asked questions

Is Outlook Therapeutics (OTLK) stock halal to invest in?
No. As of , OTLK is not Shariah-compliant under AAOIFI standards, so it is not considered halal to invest in. Outlook Therapeutics fails the business screen, the financial screen or both, based on its most recent financial reports. The Zoya app shows which one and lists Shariah-compliant alternatives.
Does Outlook Therapeutics have any interest income?
Yes, Outlook Therapeutics does have interest income. According to the company's latest annual report for the fiscal year ending Sep 30, 2025, Outlook Therapeutics reported revenue of $1,413,535 and interest income of $89,738. The interest income represents 6.35% of the combined total. It's worth noting that some companies may report additional interest income as part of their revenue. For a detailed breakdown of all interest income and revenue segments, please refer to the full Shariah compliance report available in the Zoya app.
What guidelines are used to determine if Outlook Therapeutics stock is Shariah-compliant?
We use the guidelines set by the Accounting and Auditing Organization for Islamic Financial Institutions (AAOIFI) to assess Shariah compliance. AAOIFI is a leading international organization that establishes standards for Islamic finance. Their guidelines help determine if a company's business activities and financial structure align with Islamic principles. These standards are widely respected in the Islamic finance industry and provide a consistent framework for evaluating the Shariah compliance of stocks and other financial instruments. AAOIFI's Shariah board includes renowned scholars such as Sheikh Muhammad Taqi Usmani, Sheikh Mohamed Ali Elgari, Sheikh Abdullah AlManea, Sheikh Nizam Yaquby, and Dr. Aznan Hassan.
How often is Outlook Therapeutics stock reviewed for Shariah compliance?
The Shariah compliance status of Outlook Therapeutics stock is reviewed on a regular basis, with a minimum frequency of once per quarter. However, if there are any significant changes or major developments in the company's operations that may impact its compliance, an immediate review will be conducted to ensure ongoing adherence to Shariah principles.
How can I stay updated on Outlook Therapeutics's compliance status?
To stay informed, we recommend regularly checking Zoya for updates. You can also enable alerts within the Zoya app to receive notifications whenever there is a change in the Shariah compliance of OTLK, or any other stocks you are monitoring. This is particularly useful as Shariah compliance can fluctuate due to changes in a company's financial ratios or business activities.
Are dividends from Outlook Therapeutics stock considered halal?
No, dividends from OTLK are not considered halal because the stock is currently not Shariah-compliant. When a stock is non-compliant, any dividends received from it are considered impermissible income and should be donated to charity as a form of purification. To learn more about the purification process and how to handle impermissible income, read our comprehensive guide.
Do I need to pay Zakat on my Outlook Therapeutics shares?
If you hold Outlook Therapeutics stock as an investment, through an Employee Stock Ownership Plan (ESOP), stock options, restricted stock units (RSUs), or any other form of stock ownership, and meet the Nisab threshold, you may be required to pay Zakat on it. The calculation of Zakat on investments can be complex and depends on various factors. To help make this easy, we've created a free Zakat calculator for stocks. For a more seamless experience, use the Zoya mobile app, where you can link your brokerage account to automatically import holdings.

Community posts

Related stocks

See how Outlook Therapeutics compares with its peers:
Shariah compliance data powered by the Zoya API. Chart by TradingView
l10n-embeds